Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🚫 This provider appears on the OIG List of Excluded Individuals/Entities (LEIE)
Exclusion type: 1128b4 · Date: 20251218 · State: FL
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,877
Total Claims
$1.1M
Drug Cost
702
Beneficiaries
$1,512
Cost/Patient
Risk Score Breakdown 38/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+141%
Opioid rate vs peers
5.4% vs 2.2% avg
+7%
Cost per patient vs peers
$1,512 vs $1,411 avg
+11%
Brand preference vs peers
11.8% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
5.4%
Opioid Rate
586
Opioid Claims
$26K
Opioid Cost
9.4%
Long-Acting Rate
Brand vs Generic
Brand: 1,272 claims · $834K
Generic: 9,546 claims · $225K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 131 | $136K |
| Empagliflozin | 63 | $86K |
| Semaglutide | 60 | $81K |
| Dulaglutide | 57 | $77K |
| Sitagliptin Phosphate | 55 | $65K |
| Rivaroxaban | 47 | $43K |
| Dapagliflozin Propanediol | 23 | $26K |
| Insulin Glargine,hum.Rec.Anlog | 33 | $20K |
| Insulin Detemir | 22 | $16K |
| Oxycodone Hcl | 12 | $13K |
| Insulin Aspart Prot/Insuln Asp | 11 | $12K |
| Insulin Nph Hum/Reg Insulin Hm | 20 | $9,607 |
| Colesevelam Hcl | 27 | $7,899 |
| Levothyroxine Sodium | 489 | $7,720 |
| Rosuvastatin Calcium | 380 | $7,126 |
Prescribing Profile
Patient Profile
76
Avg Age
56%
Female
1.18
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About